Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Monitoring of Early Disease Progression in Hereditary Transthyretin Amyloidosis

NCT03431896 is registered in ClinicalTrials.gov with The Cleveland Clinic as lead sponsor.

NCT NCT03431896
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03431896 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Monitoring of Early Disease Progression in Hereditary Transthyretin Amyloidosis
Lead sponsor
The Cleveland Clinic
Phase
Observational
Overall status
Completed
Start date
February 1, 2018
Completion date
March 9, 2026
Enrollment
37 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

al amyloidosis, amyloid, amyloid - primary, amyloid cardiomyopathy, amyloid neuropathies, familial, amyloidosis, transthyretin amyloidosis